BACKGROUND: Noncompliance with radiotherapy (RT) protocol guidelines has been linked to inferior clinical outcomes. We performed a meta-analysis of cooperative group trials to examine the association between RT quality assurance (QA) deviations and disease control and overall survival (OS). METHODS: We searched MEDLINE and the Cochrane Central Register of Controlled Trials for multi-institutional trials that reported clinical outcomes in relation to RT QA results. Hazard ratios (HRs) describing the association between RT protocol noncompliance and patient outcomes were extracted directly from the original studies or calculated from survival curves. Inverse variance meta-analyses were performed to assess the association between RT QA deviations and OS. A second meta-analysis tested the association between RT QA deviations and secondary outcomes, including local or locoregional control, event-free survival, and relapse. Random-effects models were used in cases of statistically significant (P < .10) effect heterogeneity. The Egger test was used to detect publication bias. All statistical tests were two-sided. RESULTS: Eight studies (four pediatric, four adult) met all inclusion criteria and were incorporated into this analysis. The frequency of RT QA deviations ranged from 8% to 71% (median = 32%). In a random-effects model, RT deviations were associated with a statistically significant decrease in OS (HR of death = 1.74, 95% confidence interval [CI] = 1.28 to 2.35; P < .001). A similar effect was seen for secondary outcomes (HR of treatment failure = 1.79, 95% CI = 1.15 to 2.78; P = .009). No evidence of publication bias was detected. CONCLUSION: In clinical trials, RT protocol deviations are associated with increased risks of treatment failure and overall mortality.
BACKGROUND: Noncompliance with radiotherapy (RT) protocol guidelines has been linked to inferior clinical outcomes. We performed a meta-analysis of cooperative group trials to examine the association between RT quality assurance (QA) deviations and disease control and overall survival (OS). METHODS: We searched MEDLINE and the Cochrane Central Register of Controlled Trials for multi-institutional trials that reported clinical outcomes in relation to RT QA results. Hazard ratios (HRs) describing the association between RT protocol noncompliance and patient outcomes were extracted directly from the original studies or calculated from survival curves. Inverse variance meta-analyses were performed to assess the association between RT QA deviations and OS. A second meta-analysis tested the association between RT QA deviations and secondary outcomes, including local or locoregional control, event-free survival, and relapse. Random-effects models were used in cases of statistically significant (P < .10) effect heterogeneity. The Egger test was used to detect publication bias. All statistical tests were two-sided. RESULTS: Eight studies (four pediatric, four adult) met all inclusion criteria and were incorporated into this analysis. The frequency of RT QA deviations ranged from 8% to 71% (median = 32%). In a random-effects model, RT deviations were associated with a statistically significant decrease in OS (HR of death = 1.74, 95% confidence interval [CI] = 1.28 to 2.35; P < .001). A similar effect was seen for secondary outcomes (HR of treatment failure = 1.79, 95% CI = 1.15 to 2.78; P = .009). No evidence of publication bias was detected. CONCLUSION: In clinical trials, RT protocol deviations are associated with increased risks of treatment failure and overall mortality.
Authors: Jeffrey F Williamson; Peter B Dunscombe; Michael B Sharpe; Bruce R Thomadsen; James A Purdy; James A Deye Journal: Int J Radiat Oncol Biol Phys Date: 2008 Impact factor: 7.038
Authors: S M Bentzen; J Bernier; J B Davis; J C Horiot; G Garavaglia; J Chavaudra; K A Johansson; M Bolla Journal: Eur J Cancer Date: 2000-03 Impact factor: 9.162
Authors: Azza A Khalil; Søren M Bentzen; Jacques Bernier; Michele I Saunders; Jean-Claude Horiot; Walter Van Den Bogaert; Bernard J Cummings; Stanley Dische Journal: Int J Radiat Oncol Biol Phys Date: 2003-03-01 Impact factor: 7.038
Authors: Roger E Taylor; Clifford C Bailey; Kathryn J Robinson; Claire L Weston; David Ellison; James Ironside; Helen Lucraft; Richard Gilbertson; Diana M Tait; Frank Saran; David A Walker; Barry L Pizer; Linda S Lashford Journal: Int J Radiat Oncol Biol Phys Date: 2004-03-15 Impact factor: 7.038
Authors: J E White; T Chen; J McCracken; P Kennedy; H G Seydel; G Hartman; J Mira; M Khan; F Y Durrance; O Skinner Journal: Cancer Date: 1982-09-15 Impact factor: 6.860
Authors: Geoffrey S Ibbott; W F Hanson; Elizabeth O'Meara; Robert R Kuske; Douglas Arthur; Rachel Rabinovitch; Julia White; Raymond M Wilenzick; Irene Harris; Ramesh C Tailor Journal: Int J Radiat Oncol Biol Phys Date: 2007-12-01 Impact factor: 7.038
Authors: Roger E Taylor; Paul H J Donachie; Claire L Weston; Kathryn J Robinson; Helen Lucraft; Frank Saran; David W Ellison; James Ironside; David A Walker; Barry L Pizer Journal: Radiother Oncol Date: 2009-03-26 Impact factor: 6.280
Authors: Stephanie C Krejcarek; P Ellen Grant; John W Henson; Nancy J Tarbell; Torunn I Yock Journal: Int J Radiat Oncol Biol Phys Date: 2007-04-20 Impact factor: 7.038
Authors: Kevin L Moore; Rachel Schmidt; Vitali Moiseenko; Lindsey A Olsen; Jun Tan; Ying Xiao; James Galvin; Stephanie Pugh; Michael J Seider; Adam P Dicker; Walter Bosch; Jeff Michalski; Sasa Mutic Journal: Int J Radiat Oncol Biol Phys Date: 2015-04-03 Impact factor: 7.038
Authors: Horia Vulpe; Janet Ellis; Shao Hui Huang; Eshetu G Atenafu; Raymond W Jang; Gary Rodin; Jolie Ringash Journal: Support Care Cancer Date: 2016-11-04 Impact factor: 3.603
Authors: Vinai Gondi; Yunfeng Cui; Minesh P Mehta; Denise Manfredi; Ying Xiao; James M Galvin; Howard Rowley; Wolfgang A Tome Journal: Int J Radiat Oncol Biol Phys Date: 2015-01-10 Impact factor: 7.038
Authors: Anshu K Jain; Sanjay Aneja; Clifton D Fuller; Adam P Dicker; Caroline Chung; Erika Kim; Justin S Kirby; Harry Quon; Clara J K Lam; William C Louv; Chris Ahern; Ying Xiao; Todd R McNutt; Nadine Housri; Ronald D Ennis; John Kang; Ying Tang; Howard Higley; Michelle A Berny-Lang; Kevin A Camphausen Journal: JCO Clin Cancer Inform Date: 2020-08